No studies of repaglinide in pregnant or breast-feeding women have been performed. Therefore the safety of repaglinide in pregnant and breast-feeding women cannot be assessed. Data from reprotoxicology studies in animals is described in Pharmacology: Toxicology: Preclinical safety data under Actions.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
